Korean Statistical Information Service. The number of death and mortality by cause of death in 2014 [Internet]. Daejeon: Statistics Korea; 2015. [cited 2015 Nov 25].
Available from:
http://kosis.kr
World Health Organization. The top 10 causes of death [Internet]. Geneva:World Health Organization. [cited 2017 Jan 31].
Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-97.
Pearson TA. New tools for coronary risk assessment: what are their advantages and limitations? Circulation 2002; 105: 886-92.
Menotti A, Puddu PE, Lanti M. Comparison of the Framingham risk function-based coronary chart with risk function from an Italian population study. Eur Heart J 2000; 21: 365-70.
Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014; 129(25 Suppl 2): S1-45.
Mackenbach JP, Stirbu I, Roskam AJ, Schaap MM, Menvielle G, Leinsalu M, et al. Socioeconomic inequalities in health in 22 European countries. N Engl J Med 2008; 358: 2468-81.
Kumari M, Head J, Marmot M. Prospective study of social and other risk factors for incidence of type 2 diabetes in the Whitehall II study. Arch Intern Med 2004; 164: 1873-80.
Korea Institute for Health and Social Affairs. Establish of new health plan 2010. Seoul: Korea Institute for Health and Social Affairs; 2006. Report No.:2005-74-2.
Chandola T, Brunner E, Marmot M. Chronic stress at work and the metabolic syndrome: prospective study. BMJ 2006; 332: 521-5.
Chandola T, Bartley M, Sacker A, Jenkinson C, Marmot M. Health selection in the Whitehall II study, UK. Soc Sci Med 2003; 56: 2059-72.
Wannamethee SG, Shaper AG, Lennon L, Morris RW. Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med 2005; 165: 2644-50.
Karlamangla AS, Merkin SS, Crimmins EM, Seeman TE. Socioeconomic and ethnic disparities in cardiovascular risk in the United States, 2001-2006. Ann Epidemiol 2010; 20: 617-28.
Kim HL, Kim YS. A study of differences in chronic diseases prevalence between socioeconomic classes. J Korean Soc Health Stat 2003; 28: 56-66.
Park MJ, Yun KE, Lee GE, Cho HJ, Park HS. The relationship between socioeconomic status and metabolic syndrome among Korean adults. Korean J Obes 2006; 15: 10-7.
Choi YH, Jeong JY, Kwak KS, Kang SH, Jang SN, Choi YJ, et al. The prevalence and risk factors of the metabolic syndrome among local residents aged 45 or over in Chuncheon: Hallym Aging Study. J Korean Acad Fam Med 2006; 27: 190-200.
Bigert C, Gustavsson P, Hallqvist J, Hogstedt C, Lewné M, Plato N, et al. Myocardial infarction among professional drivers. Epidemiology 2003; 14:333-9.
Bennett S. Socioeconomic inequalities in coronary heart disease and stroke mortality among Australian men, 1979-1993. Int J Epidemiol 1996; 25: 26675.
Kim JY, Kim SH, Cho YJ. Socioeconomic status in association with metabolic syndrome and coronary heart disease risk. Korean J Fam Med 2013;34: 131-8.